Defense procurement rules prohibiting Chinese rare earth materials starting in 2027 are reshaping U.S. manufacturing supply chains as companies build domestic processing capacity ahead of the deadline.1
The policy shift comes as industrial manufacturers face near-term earnings pressures. Deere's CEO characterized 2026 as "the bottom of the cycle" for the company, reflecting broader weakness across manufacturing sectors.2
Several manufacturers are restructuring operations to capture reshoring opportunities. Eos Energy Enterprises expanded annual capacity to 2 GWh in 2025 and secured over $240 million in fourth quarter bookings. The company projects 2026 will focus on "disciplined scale and margin improvement—driving manufacturing efficiency, improving unit economics quarter-over-quarter, and converting backlog into high-quality revenue."3
Brady Corporation issued fiscal 2026 guidance assuming a 21 percent tax rate, $44 million in depreciation and amortization, and $45 million in capital expenditures. The forecast assumes continued economic growth despite current industrial weakness.4
The rare earth supply chain transformation extends beyond defense applications. North American processing facilities including SRC and Eastover Mill are expanding capacity to reduce dependence on Chinese sources across multiple industrial applications.
Reshoring trends are expected to drive long-term electricity demand and infrastructure investment. Manufacturing executives are balancing immediate operational efficiency improvements with positioning for multi-year supply chain restructuring.
Housing manufacturers are also targeting domestic expansion. BOXABL stated it is "on a mission to solve the global housing crisis" through scaled U.S. manufacturing, though near-term execution remains focused on unit economics.5
The convergence of defense policy mandates and industrial cycle timing creates challenges for manufacturers managing capital allocation. Companies must fund capacity expansion while navigating compressed margins during the cyclical downturn.
Financial impact varies by exposure to defense procurement versus commercial markets. Firms with direct defense contracts face harder 2027 deadlines, while commercial manufacturers have flexibility to pace reshoring investments based on demand recovery.
